Akebia Therapeutics, Inc.
Revenue Breakdown
| Fiscal Year | Auryxia product revenue net | Vafseo product revenue net | Collaboration revenue | License collaboration and other revenue |
|---|---|---|---|---|
| FY2021 | $142.2M | $0 | $0 | $71.4M |
| FY2022 | $177.1M | $0 | $0 | $115.5M |
| FY2023 | $170.3M | $0 | $0 | $24.3M |
| FY2024 | $152.2M | $0 | $0 | $8.0M |
| FY2025 | $181.5M | $45.8M | $0 | $8.9M |